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The current anti-doping policy (‘war on doping’) resembles the ‘war on drugs’ in several aspects, including a
zero-tolerance approach, ideology encroaching on human rights and public health principles, high cost using
public money for repression and control, and attempts to shape internationally harmonized legal frameworks to
attain its aim. Furthermore, even if for different reasons, both wars seem not to be able to attain their objectives,
and possibly lead to more harm to society than they can prevent.
The Olympic buzz is mounting and we can expect multiple headlines in the media on doping and anti-doping
stories related to this event. In this article we describe current anti-doping policy, reflect on its multiple unplanned
consequences, and end with a discussion, if lessons learned from harm reduction experiences in the illicit drugs
field could be applied to anti-doping.Editorial
Early this year the unveiling of the brand new 2012 London
Olympics anti-doping lab made the headlines worldwide,
accompanied by strong anti-doping messages for prospect-
ive Olympians and illustrated by an iconic photograph
depicting the laboratory’s head showing a blood sample to
the Minister for Sports and the Olympics (Figure 1). The
4’400 m2 laboratory, sponsored by a multinational pharma-
ceutical company, will be operating 24 h/day during the
Games, analysing urine and blood samples of one out of
two participating athletes while a part of the samples will
be stored for eight years, using the threat of future testing
technology as a further deterrent. With the Olympic buzz
mounting and the Games monopolizing the media, the mo-
ment seems right for debate on drugs and sports among
those concerned by drug policymaking and the harm
reduction movement in specific. But you may ask yourself:
What have the Olympic Games to do with harm reduction?
More than you might think.The world anti-doping agency
The Olympic movement was the driving force behind
the anti-doping efforts that led to the establishment of
the World Anti-Doping Agency in 1999. A series of
widely publicized doping scandals and public outrage in
the nineties triggered this increasingly strong movement* Correspondence: bengt.kayser@unige.ch
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distribution, and reproduction in any mediumadvocating doping-free sports. WADA aims at eradicating
doping by harmonizing anti-doping practices worldwide
from a zero-tolerance standpoint. It is backed by the
UNESCO anti-doping convention, now signed by a ma-
jority of UN member states. These anti-doping efforts
were recently dubbed ‘war on doping’ [1], echoing the
declaration of the ‘war on drugs’ by president Nixon in
1971. These wars on drugs and on doping share various
features, such as similarities between policies based on
zero-tolerance, repression and surveillance, black mar-
kets controlled by organized crime, attempts to shape
internationally harmonized legal frameworks, ideology
and political convenience anchored in media-fuelled
moral outrages. Furthermore, when WADA was estab-
lished and drafted its first list of forbidden substances,
the question rose on whether cannabis derivatives
should be on the list. They were included largely be-
cause of pressure from the ‘war on drugs’ movement,
even though there are no known proven performance
enhancing effects but rather evidence for the contrary
[2,3]. Even though only forbidden during competitions,
regularly athletes are indicted because of urine traces of
cannabis metabolites, which may remain measurable up
to weeks after use. Cocaine metabolites are also regu-
larly found and the public announcement of such cases
often leads to important media coverage, strongly con-
demning the athlete, even if the substance was taken in
a recreational context and not for sport performance
enhancement. Whereas the ‘war on drugs’ proved to be
a failure and public debate is now slowly shiftingntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 From right to left: Prof David Cowan from King’s College London’s Drug Control Centre and Director of the London Anti-Doping
Laboratory, Sir Andrew Witty, CEO of multinational GSK (laboratory sponsor), Paul Deighton, London 2012 Chief Executive, and Hugh
Robertson, Minister for Sports and the Olympics (LOCOG, with permission).
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principles - to deal with psychotropic drug use in soci-
ety, in sport current policy is still essentially based on
repression and surveillance from a zero-tolerance view-
point. As such anti-doping thus provides the ‘war on
drugs’ movement a convenient backdoor to continue
advocating its zero-tolerance ideology.
What is doping?
The readers of this journal are perhaps not fully aware
of what is considered as doping and how anti-doping
works. Operationally, in sports, doping is defined in the
‘Code’ [4]: “the occurrence of one or more of the anti-
doping rule violations set forth in Article 2.1 through Article
2.8 of the Code”. Violations of the anti-doping rule in-
clude not only the use or attempted use of prohibited
substances, but also the presence of a prohibited sub-
stance, or its metabolites or markers, in an athlete’s
urine or blood sample; violation of the athlete’s obliga-
tion to inform about his/her ‘whereabouts’ (see below);
tampering or attempted tampering with doping control
procedures; possession of prohibited substances or the
means for performing prohibited methods; and trafficking
or attempted trafficking in a prohibited substance or the
means for performing a prohibited method [4]. Important
is also the so-called ‘strict liability’ rule, which states that
an athlete is responsible for the presence of a substance or
its metabolites in a bodily specimen, whatever the way it
was introduced into the body.
The complexity of anti-doping
Upon first glance the anti-doping rule may seem reason-
able and simple, but when looking more closely at theconsequences of the rule, questions arise. Some recent
examples of indictments for doping, illustrating the com-
plexity of anti-doping policy implementation, are given
hereunder.
Dwain Chambers, a famous British 100 m runner,
tested positive for THG (tetrahydrogestrinone) in 2003 and
was banned from competition for 2 years. The British
Olympic Association, on the basis of a bylaw, excluded
him for life from participation to the Olympics. The Court
of Arbitration for Sports (CAS) overruled this decision in
April 2012 after an appeal by WADA, opening the way for
Chambers to compete in this summer’s Olympics. The
case is illustrative for several reasons. First because of the
substance THG (aka ‘The Clear’). It was designed by a
clandestine laboratory specifically for doping purposes, and
by consequence unknown to the scientific community
and anti-doping laboratories in particular. It was dis-
covered when a coach sent a syringe containing traces
of the substance to the USA anti-doping agency. Sec-
ond because there are no published experimental data
confirming the alleged performance enhancing effects
of the substance. Third, since WADA convinced CAS
to overturn the ruling of BOA on the basis of non-
compliance to universally applicable WADA rules.
And fourth, because of the strong condemning of this
CAS ruling by many prominent members of the
British sports-establishment which seemed to indicate
that a doping offence is not seen in the same way as
most other offenses in society; if in general, upon pun-
ishment for transgression of a rule, one is offered a
second chance, a doping offense is deemed essentially
unforgivable and worth exclusion of sports for life. As
Sebastian Coe, chairman of the London Organising
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cut on the Chambers case – I don’t think there is room
for drugs cheats in sport”.a
Alberto Contador, a famous Spanish road-cyclist and
Tour-de-France winner, was indicted in 2012 for trace
levels of clenbuterol in urine samples obtained during
the 2010 Tour. Several aspects set this case apart. First
because of the long time it took to condemn Contador,
contrasting his case with several other similar cases in
other, perhaps less famous athletes. Second, the traces
found were so low as to exclude any significant physio-
logical performance enhancing effects around the time
of sampling. Third, the excuse used by the defence: in-
gestion of contaminated meat. And fourth, the widely
publicized rumours about possible blood doping as the
source of the substance, by transfusion of Contador’s
own blood, extracted and stored at an earlier time when
doping, on the basis of traces of plastic residues in his
blood, compatible with the use of blood bags and tubing,
even though his blood parameters did not indicate blood
doping.
Christine Ohuruogu is a very successful British athletics
sprinter who was suspended from competition in 2006,
not because of doping, but because she missed three un-
announced out-of-competition drug tests. She received a
one-year ban for missing these tests, even though she was
repeatedly tested at other occasions in the same period as
the missed tests, without any adverse findings. This would
rather indicate negligence on informing the authorities on
her ‘whereabouts’ and not intentional doping-hiding be-
haviour. Nevertheless BOA initially imposed a lifetime
ban from competing at future Olympics. Her Olympic ban
was finally overturned in November 2007.
Yanina Wickmayer is a talented young tennis player from
Belgium whom end 2009 was initially suspended for a year
by the Flemish anti-doping authority. She had failed three
times to inform about her whereabouts upon entering the
Women’s Tennis Association top-50 and by consequence
becoming part of the athlete pool obliged to inform about
her whereabouts. She was able to defend herself in a
Belgian court, pointing out shortcomings and administra-
tive errors of the official bodies overseeing her introduction
to whereabouts obligations and had the ban overturned,
allowing her to play again, but her image was probably
tainted forever. But her case is not over yet. Even though
WADA, claiming a 2-year suspension, has decided to with-
draw its appeal against the Flemish anti-doping authority
following the decision of a Belgian court to invalidate the
authority’s decree, the procedure between the player and
the Flemish Tennis Federation has only been suspended for
the moment.
Claudia Pechstein, a very successful German speed
skater, was frequently tested throughout her long career,
but never failed a test. On the basis of fluctuations inthe number of young red blood cells in her blood (reti-
culocytes), she was declared guilty of blood doping in
2009 and banned from competitions for two years. This
case is interesting because it was the first time that an
athlete was considered guilty of doping on indirect evi-
dence indicating the possible use of a substance that, in
itself or its metabolites, were not directly identified. Per-
haps the fact that Pechstein’s career started as an East
German skater created a climate of suspicion because of
state-organized doping practices in former East Germany.
But in hindsight it is now highly likely that Pechstein’s
higher than ‘normal’ levels of reticulocytes result from a
genetic anomaly, and are, in her case, physiological and not
the result from doping. In all there remains considerable
scientific doubt on the likelihood that Pechstein did indeed
use forbidden substances or methods. The case also high-
lights the difficulties for the CAS to rule in such compli-
cated cases, because of the entangling of scientific, legal,
economical, political and personal interests.
Pluim [5] reviewed a series of cases of doping in tennis.
There were 40 cases in the 5-year period 2003– 2007, but
in only 13 of these a prohibited substance was taken to en-
hance performance. In the other cases (68%) it was
accepted at independent hearings that there was “no intent
to enhance performance” or “no (significant) fault or negli-
gence”. Recreational drugs made up 40% of the cases (11
cases of cannabis, 5 of cocaine).
Finally, an unknown number of athletes likely remain
undiscovered and get away with some forms of doping.
This is because of the limits to surveillance and labora-
tory testing technology. The ideal situation would be
black and white: the forbidden substance is present or
is not present in a urine or blood sample. Those two
extreme cases exist, but there is, depending on the sub-
stance, often a large area of uncertainty. A test can be
positive (showing the presence of a substance) when it
is indeed present (true positive) or not present (false
positive); conversely, a test can be negative when there
is indeed no substance present (true negative) or when
in fact the substance is present (false negative). Anti-
doping policy enforcers need to keep false positives as
low as possible, while striving for the highest sensitivity
possible. The probability for false positives rises with
the number of tests performed, as well as with a drop
in prevalence of actual doping [6]. Furthermore, for
some forms of doping practices there exist no labora-
tory tests. WADA does not want to publish WADA-
accredited laboratories’ test performance, saying that
this would permit athletes tailoring doping practice to
current testing technology. At first sight, this seems
reasonable, but, at the same time, it leaves room for
doubt about the impartial nature of anti-doping testing.
The absence of transparency is not a good gatekeeper
for quality assurance.
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in fine, a ‘clean’ sample will never allow to fully exclude
doping, while occasional sacrifice of innocent athletes from
false positives appears inevitable. Even if anti-doping efforts
certainly have changed current doping practices - certain
types of doping cannot be used anymore because too easily
discovered - the purpose of anti-doping, the celebration of
‘clean’ athletes with a strong degree of confidence, or even
certainty, thus remains an unattainable objective. One is
forced then to question whether the champions are ‘clean’;
a question that unfortunately remains unanswered. So, if
the principle of the anti-doping rule may initially seem
simple, one can see that its implementation is complicated,
very technical, highly costly, only partially successful and
condemns athletes who did not dope or had no intent to
dope.
Enforcement of anti-doping policy today
Anti-doping is enforced by a combination of repression
and surveillance. The latter includes the so-called ‘where-
abouts’ rule, or the obligation for a selected pool of elite
athletes to inform the anti-doping authorities where they
will be each day of the year, to allow unannounced out-of
(and in)-competition testing, with the obligation to be
present at the announced site for one specific hour per
day. The athletes have to provide this information to the
authorities in advance, four times a year for three months
periods at a time, using electronic and paper-based means
and informing in time of any changes [4]. This rule aims at
preventing out-of-competition doping in preparation for
competition. To force athletes to comply, three missed
tests within an 18-months period constitute a doping
offence, as happened in the Ohuruogu and Wickmayer
cases mentioned, and regularly occurs for other athletes.
The actual testing involves providing urine samples (pro-
duced in full view by an anti-doping officer), consenting to
blood sampling, and in some instances also providing hair
samples for doping history and tissue for gene profiling for
forensic practices. Longitudinal testing, looking for fluctua-
tions in certain blood parameters compatible with doping,
is now also being introduced. This practice, known as the
‘athlete biological passport’ (ABP), has recently led to the
first indictments of athletes, based on indirect indices of
presumed doping rather than laboratory tests directly
showing the presence of the forbidden substances or their
metabolites in urine or blood. The authorities see the ABP
as an improvement of anti-doping [7]. But the ABP may
produce false-positive results due to analytical variability
and outlying individual patterns resulting from the effects
of behaviour (training, altitude exposure) and genetics
[8-10].
Mostly related to its enforcement strategies, anti-doping
has a non-negligible cost [11,12]. The IOC finances half
the budget of the WADA, while the other half comes fromnational governments. National anti-doping agencies are
mostly co-financed by national sports federations and
governments. Overall the tendency is towards increasing
costs with a new costly anti-doping industry steadily asking
for more. The application of new national anti-doping
legislations also comes with an increase in cost.
Taken together, all of these costly surveillance prac-
tices seriously impinge upon the privacy of athletes and
set them apart from the general population, for whom
the protection of the private sphere and autonomy are
generally respected in democratic societies, and are at
odds with general relaxed attitudes of modern society
towards human enhancement practices such as cosmetic
surgery (e.g. [13], and with an increasing prevalence of
the use of cognitive enhancement drugs [14].
Other consequences of anti-doping
If anti-doping would only concern elite sport, one might
accept the arguments in favour of the exceptions made in
sports, for the sake of what sports aspires to be. But anti-
doping has unintended side effects outside elite sports. One
illustrative example of how anti-doping policies directly in-
fluence society outside the scope of competitive sport is the
2005 extension of Danish national anti-doping policy to
commercial fitness clubs (gyms) in which clients engage
into weight lifting and other types of exercise for health
and appearance purposes, but not necessarily for sports
competition [15]. Danish gyms have the obligation to put
either a happy green smiley on the entrance, indicating ad-
herence to Anti-Doping Denmark, which includes surprise
urine testing of clients, or an unhappy red smiley with the
explicit message that the club does not adhere to anti-dop-
ing Denmark. About 20-25% of the samples are found to
contain (forbidden) anabolic steroids. As a consequence
these clients are excluded from the gym in question for
2 years, and from all other gyms that adhere to the rule.
According to the law the client should also be excluded
from all sports in Denmark. And, as in elite sport, a refusal
to be tested is counted as a positive test [15]. This example
illustrates the potential for generalization of anti-doping
surveillance practices in society in general. This practice is
not far from the introduction of testing of students for cog-
nitive performance enhancing substances and other drugs,
and possibly other groups, like teachers, trainers, coaches,
sports referees, police personnel, amateur athletes, etc. [16].
Such increased surveillance and testing would lead to
increased numbers of convictions, with an important bur-
den imposed on the judicial system and the families of the
convicted. For simple reasons of stochastic and procedural
error frequency, a greater number of tests would lead to a
greater number of false positives, wrongly accusing inno-
cent citizens. The prospect of such a development has
worrying characteristics of a dystopia of Orwellian kind. It
appears paradoxical that gym users, generally conscious
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principles like regular exercise and a healthy diet, making a
balanced decision on steroid use to aid them in attaining
their aspired body form, are punished for anabolic steroid
use, while the general population can freely engage in dan-
gerous behaviour combining bad nutrition, lack of exercise,
tobacco and alcohol use without much of a constraint.
What end justifies anti-doping?
Because of the problems of current anti-doping policy
the question arises as to what the reasons for the anti-
doping endeavour are. The main justification for anti-
doping is formulated as follows in the ‘Code’, the central
document published by WADA outlining anti-doping:
“Anti-doping programs seek to preserve what is
intrinsically valuable about sport. This intrinsic value
is often referred to as “the spirit of sport”, it is the
essence of Olympism; it is how we play true. The spirit
of sport is the celebration of the human spirit, body
and mind, and is characterized by the following
values: Ethics, Fair play and honesty, Health,
Excellence in performance, Character and education,
Fun and joy, Teamwork, Dedication and commitment,
Respect for rules and laws, Respect for self and other
Participants, Courage, Community and solidarity.
Doping is fundamentally contrary to the spirit of
sport.”b
According to WADA the spirit of sport is thus the
celebration of the human spirit, body and mind. The
reasons advanced against doping are that it skews a level
playing field, can threaten the health of the athlete, is
against the spirit of sport, and incompatible with the
concept of the athlete as a role model. All these argu-
ments are problematic as the first author and several co-
authors have explained before [11,17,18]. Elite sport is
by definition a non-level playing field since it is about
the celebration of differences. The protection of the
health of the athlete argument is paternalistic and
neglects the health hazards of sport itself while the dis-
tinction of avoidable and unavoidable risk is flawed.
Moreover, the spirit of sport argument is fuzzy and
fraught with problems, and the role-model argument is
out of perspective as compared with any other role
model in society. Anti-doping policies in sports have
created an image of an idealized ‘perfect’ human. Obli-
ging athletes to correspond to this ideal appears unfair
compared to what is asked of other citizens.
Why do athletes dope and will probably continue doing
so?
Doping has always been part of sports. Already at its an-
cient Olympic roots and also at the beginning of modernsports about a century ago, athletes have always looked for
and applied any ways imaginable to increase performance,
be it by taking substances or by using methods [19,20].
Taking as an example the Tour de France, it can be posited
that in the last century, in virtually each year the winner
and/or runner-ups were either known to have used doping
or strongly suspected of having done so [21]. Aspiring to
organize a Tour without doping can therefore be seen as
trying to invent a Tour that has never existed before. The
difference between earlier and more recent Tours, admit-
tedly important, is the kind of performance enhancing
technology that has been made available by the biomedical
revolution over the last decades. If in the early days of
sports the arsenal of performance enhancing compounds
was quite limited, today’s advances of biomedical science
have indeed opened up Pandora’s box with unlimited pos-
sibilities but also increased health risks. Since a doping
culture has always been part of cycling it is quite under-
standable that these new possibilities from bio-medical
research were, and still are being exploited for performance
enhancement practices by cyclists and their entourage.
WADA’s claim that a culture of doping-free sport will de-
velop and help attain the eradication of doping in sports
remains to be proven; for competitive road-cycling, recent
publications suggest that although doping practices cer-
tainly have changed, a culture of doping in professional
cycling still prevails [22]. A provocative editorial in the
journal Nature in 2007 proposed that perhaps the Tour de
France should be the first competition to accept pharma-
cological performance enhancement [23].
Given the fact that in spite of the increasingly repressive
means employed to combat doping, athletes are regularly
caught - while others probably get away with it - the ques-
tion arises: why do athletes continue taking the risk? The
underlying question is whether current anti-doping policy
in sports, striving for a world free of doping in elite sports,
is commensurate with how human (doping-) behaviour is
determined. Using a point of view from a sociocultural
perspective, but interpreting behaviour as partly deter-
mined by our evolutionary past, we suggest that doping in
athletes is perfectly natural human behaviour. Given what
modern sport is today, i.e. an important entertainment en-
terprise in which large amounts of money go round,
strongly biased towards the celebration of winners and
applying the general concept of ‘winner takes all’, it is not
surprising that athletes can be drawn to whatever promises
an edge in competition. The official credo of the Olympic
movement is ‘Citius, Altius, Fortius’, or faster, higher, stron-
ger. It is often completed by the phrase ‘The most import-
ant thing is not to win but to take part’ [24]. But the latter
is not reflected by reality. Today an important tenet of elite
sport is the celebration of the winner. This puts a lot of
pressure on athletes, who are perpetually seeking the
competitive advantage. As Petroczi [25] states: “using
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ing behaviour than deviance”.
What does it take to be a champion? The ingredients are
a combination of talent, hard work and some luck. Talent is
a licit, albeit unmerited gift and results from the genetic lot-
tery. Hard work is essentially training and using any other
means that are allowed to improve performance. Perform-
ance enhancement is a logical and essential ingredient of
competitive sport. Athletes look for ways to get better, by
changing their training paradigm, by eating differently, by
taking vitamins, by taking licit medication, by taking sup-
plements. A huge sports supplements industry exists and it
is very common for athletes to consume a lot of substances
that are not on the list of forbidden substances [26]. In
2012 the British Journal of Sports Medicine published its
28th article on the A-Z of nutritional supplements [27] and
the list continues to grow. Many of the supplements do
nothing, a few have an effect, but quite many may pose
doping problems because of adulteration, leading to accus-
ation of doping because of positive blood or urine samples
[28] or health problems because of excess intake of some
compound, erroneously seen as innocuous [29].
Modern sport puts athletes under enormous pressure
to win and the use of licit substances and methods to
improve performance is explicitly encouraged. The line
between licit and illicit fluctuates and has dimensions
that can be perceived as arbitrary.
Transgression of doping rules is not necessarily accom-
panied by a fundamentally different mindset as when keep-
ing to the rules. In athletes’ minds, doping may align with
illicit behaviour or with functional licit use of chemical or
natural preparations [28].What if current zero-tolerance anti-doping policy continues?
What can be foreseen over the next decades if the central
tenet of the anti-doping movement - eradication of doping
- continues to drive a global agenda of surveillance and
suppression of doping and doping-like behaviour? We ex-
pect that, in the short term, continued pressure from the
WADA and the IOC, backed by the international UNESCO
convention, will oblige an increasing number of nations to
adopt specific anti-doping legislation, especially those who
aspire to organize Olympic Games. There is an inter-
national tendency to combat doping and related activities
like trafficking through criminal law (e.g. in Italy, France
and Slovenia, see [30]), quite akin to what happened in the
field of psychotropic drugs, thus criminalizing the use, pos-
session, traffic and commerce of doping substances. This
development will be accompanied by increasingly repres-
sive measures worldwide. Increasing numbers of citizens
will have to comply with compulsory drug testing for an
increasingly long list of substances.Because of such unintended effects we suggest that the
debate on anti-doping should not be a matter of concern
to elite-sports only. Still, anti-doping arguments are fre-
quently formulated which explicitly or implicitly ignore
the actual practical consequences of actual anti-doping
policies in and outside sports (see e.g. [31,32]). We be-
lieve that this is unacceptable. Just as for the ‘war on
drugs’ the consequences of the ‘war on doping’ should
be fully taken into account when engaging into the
debate on how to regulate the use of performance
enhancing substances and methods in sports.
The ‘war on drugs’, regulation and harm reduction
The Global Commission on Drug Policy has called the
‘war on drugs’ a failure and asks for change [33]. The alter-
native proposed is regulation of drug use, based on human
rights and public health principles, with a combination of
pragmatic policies taking into account local socio-cultural
and economic specificities, and continuously adapted to
on-going developments. High on the list of policies pro-
posed are treatment and harm reduction measures. Coun-
tries like the Netherlands, Switzerland and lately Portugal,
where such policies have been put in place, have shown
that these strategies are accompanied by a reduction in the
cost to society and the individual, by decreasing drug-
related mortality and morbidity, as well as crime and its
associated costs, without an increase in the prevalence of
illicit drug use [33]. Examples of, mostly evidence-based,
harm reduction measures include needle and syringe
exchange programmes, safe use facilities, opiate substitu-
tion therapy, overdose prevention and chemical analysis of
party drugs. Some of these pragmatic ways to deal with so-
cietal problems can be perceived as ‘messy’. For example,
in safe injection facilities drug users bring their own sup-
plies obtained on the black market, an idea that may be
repulsive for many. But such facilities have proved their
utility beyond any reasonable doubt, by reducing hepatitis
and HIV transmission rates, reducing the general health
burden in injecting drug user cohorts and reducing the so-
cietal costs of open drug scenes, without increasing drug
use or injecting behaviour [34]. Full liberalization of all
substance use seems currently politically inconceivable
while harsh repression has repeatedly been shown to in-
duce more harm to society than it prevents [33]. As a com-
promise between these extremes, regulation and harm
reduction is a pragmatic way to dynamically deal with such
behaviour [12,34]. It is dynamic because it has to be con-
stantly adapted to changes in population behaviour.
An alternative way to deal with doping?
The difficulties of applying a model of regulation and harm
reduction to sports are of course huge, but perhaps more
in line with anthropological generalizations of a socio-
culturally moulded, evolutionary defined ‘human nature’.
Kayser and Broers Harm Reduction Journal 2012, 9:33 Page 7 of 9
http://www.harmreductionjournal.com/content/9/1/33The choice between fighting doping by all means vs. regu-
lation and harm reduction is difficult, since neither will
solve the problem; no ultimate solution exists, it will re-
main ‘messy’. In our view, regulation and harm reduction
may come with less cost to society and the individual, as
compared to a zero-tolerance approach, and therefore mer-
its to be considered. We do not have a ready-made blue-
print to offer; if an easy way existed it would already have
been in place. As the Global Commission on Drug Policy
has proposed for the problem of illicit psychotropic drugs,
we could begin thorough evaluation of the current system
and accordingly begin changing it in a more reasonable
way, to the benefit of the athletes and to the future of
sports [33].
We would like to make some suggestions for possible
strategies. To begin with, the concept of performance en-
hancement by means of methods or substances, including
pharmacology, should be seen as a logical consequence of
elite sports endeavour and not be negated by a utopic ideo-
logical ‘spirit of sport’ concept. Second, the health of elite
athletes should still be protected, but taking into account
the specificities of this risky profession (some sports come
with a level of risk not acceptable in other professions).
This can be done by continuing some form of testing, with-
out going all the way as in today’s testing. For example, a
no-starting rule for a haematocrit above a given level, how-
ever the way it got to that level, is a pragmatic way to pre-
vent excess use of red cell mass stimulation regimes that
lead to a health hazard. Sure enough, athletes will find ways
to cheat a bit around such strategies, but that would be part
of the game while keeping the problem within acceptable
boundaries by associating such a rule with some other rules
like the exclusion of plasma expanders, if warranted. The
argument that it would change sports into an arena akin to
Formula 1 where the best engineering team wins is only
partly correct. It will still take talent, a lot of hard work and
some luck to become a champion. And then, it is likely that
such a scenario is already in place anyway; today well-
assisted athletes may engage in complex training regimes
and strategic doping while remaining undetected. Third,
the list of forbidden substances can be shortened, leaving
on the list only those substances with actually proven per-
formance enhancing effects and major health hazards. For
example, cannabis derivatives can be taken off the list,
allowing athletes to be dealt with in the same way as the
general population. The current arguments to keep canna-
bis on the list are flawed. There are no well-controlled trials
that show any performance enhancing effect, while there is
evidence for performance decreasing effects [2,3].
With regard to the general population, instead of a
crackdown on steroid users in gyms and fitness clubs with
compulsory testing as in Denmark [15], a harm reduction
approach is probably better [12]. This has already been
shown in the UK where so-called steroid clinics, givingout clean syringes and thus lowering the threshold to
medical care, have led to the number of syringes handed
out now outnumbering those exchanged for injection for
psychotropic drugs [35]. These clinics, offering mostly free
and anonymous services, make it possible to reach a previ-
ously hidden population. Potential advantages of providing
harm reduction measures, besides health benefits, include
the personal and direct contact with a hidden population
allowing it to be informed of the risks and dangers of dop-
ing substances, and helping to take well informed decisions
whether to continue use and if so in what way. These ser-
vices show promise but need to be well evaluated [36]. In
Switzerland the federal commission on drug-related affairs
developed a conceptual model (‘the cube’) considering that
for every substance, with different risk profiles, different
levels of use exist (non-problematic, problematic, depend-
ence), needing different levels of intervention at the level of
prevention, treatment, harm reduction and regulation.
Such a model might help to conceptualise alternative pol-
icies on performance enhancing substances respecting
public health and ethical principles [37].
What problems would arise?
As Donohue et al [38]. have noted with regard to the
effect of alternative psychoactive drug policies, the two
contentious questions here are also: “By how much would
the prevalence and intensity of doping rise under a differ-
ent regime?” and “Would reduction in other costs out-
weigh the risks of increased doping?”. One would have to
distinguish between elite athletes, amateur athletes, min-
ors, gym users and the public in general, since it can be
expected that the answers to these questions would vary
between groups. It is impossible to predict what would
happen in these different groups. In elite athletes one
might expect limited harm since medical supervision and
health oriented testing would constrain the possibilities.
In amateur athletes the possibility of refraining from sour-
cing substances from the black market and having access
to general information and proper methods of use, might
perhaps have a positive effect. It will of course be difficult
to devise an optimal strategy to regulate for children spe-
cifically. Since athletic careers often start very early, the
protection of young talents would be mandatory. Alterna-
tive policies should of course be continuously and exten-
sively evaluated for desired outcomes and unintended
negative consequences, carefully balancing the two.
What are the barriers to change?
WADA has been successful in giving universal value to
its Code by having the UNESCO formulate an Inter-
national Convention against Doping in Sport, which has
now been signed by sufficient member states of the UN
(165 as of early 2012) to have universal value. The Con-
vention’s intention is the elimination of doping in sports
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WADA to define doping and anti-doping. As for illicit
drugs, this makes policy changes moving away from the
hard line of zero-tolerance politically difficult to accept,
with the added difficulty that the International Olympic
Committee uses the desire of participation in the Olympic
Games as a lever to force nations to implement anti-doping
legislation in accordance with the WADA Code. It seems
that the ideal of sport as promoted by the International
Olympic Committee is attaining universal value with a legal
status that tends to supersede national law. We are worried
that the inertia of this system is such that in the next
10–20 years little change can be expected. We hope that in
the meantime the side effects of the ‘war on doping’ will
not aggravate further, and that the tendency for a fusion of
the ‘war on drugs’ with the ‘war on doping’, with excessive
surveillance and harsh repression of a dystopian nature will
be limited before it achieves truly Orwellian dimensions.
Conclusions
The UN Single Convention on Narcotic Drugs of 1961
and the declaration of the ‘war on drugs’ by president
Nixon in 1971, were fuelled by a utopian vision of a
world free of illicit psychotropic substance use - “A drug
free world—we can do it”, (cited in [39]). Anti-doping is
aiming for a similar unattainable goal, sports without
doping and has adopted the —“Just say no”— slogan
from the ‘war on drugs’ movement. The sports move-
ment has created a utopian vision of what a human
should aspire to, a young beautiful athlete with perfect
behaviour. This vision is used to lever unprecedented
means to combat drugs in sports and now also outside
sports, that put into question all what the harm reduc-
tion movement has fought for.
Many of us would probably welcome a world without
wars, drugs or doping. Still, for many reasons, perhaps
partly because of our perhaps ‘innate imperfect human
nature’, the daily reality is quite different. The use of licit
and illicit psychoactive substances is among the leading
causes of preventable death across cultures and conti-
nents. Although prevalence of illicit substance use is much
lower than prevalence of licit substance abuse (e.g. alco-
hol, tobacco), 50 years of ‘war on drugs’ have had little
effect on this prevalence but have had many negative con-
sequences. As Room and Reuters note:
“The system’s emphasis on criminalisation of drug use
has contributed to the spread of HIV, increased
imprisonment for minor offences, encouraged nation
states to adopt punitive policies (including executions,
extra-judicial killings, imprisonment as a form of
treatment, and widespread violations of UN-
recognised human rights of drug users), and impaired
the collection of data on the extent of use and harm ofillicit drugs, all of which have caused harm to drug
users and their families” [40].
The Global Commission and many scientists, public
health and law specialists have called for a transformation
of the global drug prohibition regime, with experimentation
with and evaluation of alternative regulation models, and
access to evidence-based drug treatment and harm reduc-
tion services for those in need. The Commission’s report
asks us to
“Break the taboo on debate and reform. The time for
action is now” [33].
The current anti-doping policy, in place for just over
10 years, resembles the ‘war on drugs’ in several aspects, as
we have described. The ‘war on drugs’ and the ‘war on dop-
ing’ tend to converge, as exemplified by the categorization
of steroids as class III drugs in the USA, the compulsory
drug testing for Danish gym users and the presence of can-
nabis on the list of forbidden doping substances.
Even if sufficiently complete and accurate data on the
negative aspects of anti-doping policy are still lacking, we
suggest that the taboo on debate and reform also be
broken in this field, now and not in 40 years. We cannot
ignore the side effects of current anti-doping policy for so-
ciety in general. We suggest experimentation with and
evaluation of alternative ways of dealing with doping in
elite (and amateur) sports, inspired by the experience
gained with alternative drug policies, that are scientifically
sound, respect human rights and public health, and treat
athletes as ordinary humans and not as potential crim-
inals. Regulation and harm reduction can be perceived as
‘messy’, but thanks to their pragmatic nature they might
allow overall harm to society to be reduced below its
current levels. The modern globalised sport entertainment
industry with its almost unlimited financial means should
not be allowed to hijack worldwide legal frameworks and
orient society towards a zero-tolerance approach to both
psychotropic and performance enhancing substances.
Those who are advocating harm reduction strategies to
help society live with psychotropic drugs at the lowest cost
for the individual and the community should therefore be
concerned about these developments. The 2012 Olympics
are a good occasion to foster the debate.Endnotes
ahttp://news.bbc.co.uk/sport2/hi/athletics/7631774.
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